Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can light therapy unlock stiff fingers?

NCT ID NCT07753460

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This trial tests whether adding low-level laser therapy to a standard splint can ease the pain and locking of trigger finger, a common hand condition. About 91 people with trigger finger will receive either real laser treatment or a sham (inactive) laser, three times a week for four weeks, while all wear a splint. Researchers will compare changes in pain, triggering severity, and hand function between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Low-level laser therapy (LLLT) plus a splint, compared to a sham laser plus a splint
What this could lead to
If effective, adding low-level laser therapy to standard splinting could offer a non-invasive way to reduce pain and finger locking, potentially delaying or avoiding the need for injections or surgery.
What could go wrong
This is a relatively small trial, and the sham-controlled design means the true benefit may be modest. Low-level laser therapy is generally safe, but results may not apply to all cases, especially severe ones.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 91 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Applying to the outpatient clinic of the Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Dokuz Eylül University * A clinical diagnosis of trigger finger based on typical pain and tenderness over the A1 pulley accompanied by triggering of the affected finger * Willingness to participate in the study Exclusion Criteria: * Multiple trigger fingers in the same hand * Fixed deformity (Quinnell grade 4) * Splint treatment, physical therapy, or steroid injection for the affected trigger finger within the previous 6 months * Previous surgery for the affected trigger finger * Musculoskeletal disorders or peripheral nerve injury involving the ipsilateral upper extremity * Rheumatoid arthritis, carpal tunnel syndrome, Dupuytren disease, amyloidosis, or mucopolysaccharidosis * Active infection, bleeding, skin lesions, or an implant at the treatment site * Radiotherapy within the previous 6 months * Photodermatosis, photosensitivity, or systemic lupus erythematosus * Pregnancy, epilepsy, coagulopathy, active malignancy, or the presence of a cardiac pacemaker * Cognitive impairment that precludes understanding of the study questionnaires.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stenosing tenosynovitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dokuz Eylul University

    RECRUITING

    Izmir, Balçova, 35330, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.